Updated results from BELLINI, a phase III study of venetoclax or placebo in combination with bortezomib and dexamethasone in relapsed/refractory multiple myeloma.
Publication
, Conference
Kumar, S; Harrison, SJ; Cavo, M; de La Rubia, J; Popat, R; Gasparetto, C; Hungria, V; Salwender, H; Suzuki, K; Kim, I; Gay, F; Mikala, G ...
Published in: JOURNAL OF CLINICAL ONCOLOGY
2020
Duke Scholars
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
15
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Kumar, S., Harrison, S. J., Cavo, M., de La Rubia, J., Popat, R., Gasparetto, C., … Moreau, P. (2020). Updated results from BELLINI, a phase III study of venetoclax or placebo in combination with bortezomib and dexamethasone in relapsed/refractory multiple myeloma. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 38).
Kumar, Shaji, Simon J. Harrison, Michele Cavo, Javier de La Rubia, Rakesh Popat, Cristina Gasparetto, Vania Hungria, et al. “Updated results from BELLINI, a phase III study of venetoclax or placebo in combination with bortezomib and dexamethasone in relapsed/refractory multiple myeloma.” In JOURNAL OF CLINICAL ONCOLOGY, Vol. 38, 2020.
Kumar S, Harrison SJ, Cavo M, de La Rubia J, Popat R, Gasparetto C, et al. Updated results from BELLINI, a phase III study of venetoclax or placebo in combination with bortezomib and dexamethasone in relapsed/refractory multiple myeloma. In: JOURNAL OF CLINICAL ONCOLOGY. 2020.
Kumar, Shaji, et al. “Updated results from BELLINI, a phase III study of venetoclax or placebo in combination with bortezomib and dexamethasone in relapsed/refractory multiple myeloma.” JOURNAL OF CLINICAL ONCOLOGY, vol. 38, no. 15, 2020.
Kumar S, Harrison SJ, Cavo M, de La Rubia J, Popat R, Gasparetto C, Hungria V, Salwender H, Suzuki K, Kim I, Gay F, Mikala G, Punnoose E, Hong W-J, Sood A, Jalaluddin M, Ross JA, Pauff JM, Maciag PC, Moreau P. Updated results from BELLINI, a phase III study of venetoclax or placebo in combination with bortezomib and dexamethasone in relapsed/refractory multiple myeloma. JOURNAL OF CLINICAL ONCOLOGY. 2020.
Published In
JOURNAL OF CLINICAL ONCOLOGY
EISSN
1527-7755
ISSN
0732-183X
Publication Date
2020
Volume
38
Issue
15
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences